Ignite Creation Date:
2025-12-24 @ 7:06 PM
Ignite Modification Date:
2025-12-31 @ 9:11 PM
Study NCT ID:
NCT03300557
Status:
COMPLETED
Last Update Posted:
2025-08-29
First Post:
2017-10-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-14
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-02
First Submit QC Date:
None
Study First Post Date:
2017-10-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-05
Results First Submit QC Date:
None
Results First Post Date:
2025-06-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-06-03
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-08-19
Last Update Post Date:
2025-08-29
Last Update Post Date Type:
ESTIMATED